Texto: 
Within Normal Limits.
Non-contrast axial CT image demonstrates a well-circumscribed smoothly marginated, heterogeneous 3.5 x 3.2 cm mass arising from the left adrenal gland.  There are areas within the mass that are low density and measure 5 HU.   50 seconds postcontrast axial CT image demonstrates the lesion to enhance heterogeneously, with areas within the mass measuring 113 HU.  15-minute delay postcontrast axial CT image demonstrates the lesion to enhance heterogeneously, with areas within the mass measuring 35 HU.  The percentage enhancement washout was determined to be 72% consistent with a benign adrenal adenoma.
Benign Adrenal Adenoma
Metastases:
     (Lung, Breast, Melanoma, Gastrointestinal, and Renal Cell 
     Carcinoma )
Adrenal Myelolipoma
Benign Nonfunctional Adrenal Adenoma
Hyperfunctioning Adrenal Neoplasms with associated endocrine
     syndromes:
     (Cushingâ€™s Syndrome, Connâ€™s Syndrome, Adrenogenital syndrome in
     newborns and infants.)
     Pheochromocytoma
Infectious Etiologies:
     Tuberculosis
     Histoplasmosis 
Primary Adrenal Carcinoma
53 yo asymptomatic female with known adrenal mass.


Keywords: 
\-\ tuberculosis\\ histoplasmosis\\ primary\\ adrenal\\ carcinoma\\ 53\\ yo\\ asymptomatic\\ female\ \(0\)\
\-\ adrenal\\ myelolipoma\\ benign\\ nonfunctional\\ adrenal\\ adenoma\\ hyperfunctioning\\ adrenal\\ neoplasms\ \(0\)\
\-\ minute\\ delay\\ postcontrast\\ axial\\ ct\\ image\\ demonstrates\ \(0\)\
\-\ 50\\ seconds\\ postcontrast\\ axial\\ ct\\ image\\ demonstrates\ \(0\)\
\-\ contrast\\ axial\\ ct\\ image\\ demonstrates\ \(0\)\
\-\ benign\\ adrenal\\ adenoma\\ metastases\ \(0\)\
\-\ benign\\ adrenal\\ adenoma\ \(1\)\
\-\ 2\\ cm\\ mass\\ arising\ \(3\)\
\-\ mass\\ measuring\\ 35\\ hu\ \(0\)\
\-\ mass\\ measuring\\ 113\\ hu\ \(0\)\
\-\ known\\ adrenal\\ mass\ \(1\)\
\-\ left\\ adrenal\\ gland\ \(6\)\
\-\ renal\\ cell\\ carcinoma\ \(60\)\
\-\ measure\\ 5\\ hu\ \(0\)\
\-\ pheochromocytoma\\ infectious\\ etiologies\ \(0\)\
\-\ percentage\\ enhancement\\ washout\ \(1\)\
\-\ circumscribed\\ smoothly\\ marginated\ \(1\)\
\-\ associated\\ endocrine\\ syndromes\ \(0\)\
\-\ within\\ normal\\ limits\ \(205\)\
\-\ 5\\ x\\ 3\ \(10\)\
\-\ heterogeneous\\ 3\ \(2\)\
\-\ areas\\ within\ \(9\)\
\-\ low\\ density\ \(52\)\
\-\ infants\\ \\.\\)\ \(0\)\
\-\ enhance\\ heterogeneously\ \(3\)\
\-\ cushing\\ \\â\\€\\™\ \(0\)\
\-\ conn\\ \\â\\€\\™\ \(0\)\
\-\ adrenogenital\\ syndrome\ \(0\)\
\-\ mass\ \(4930\)\
\-\ syndrome\ \(817\)\
\-\ well\ \(2069\)\
\-\ non\ \(1889\)\
\-\ newborns\ \(8\)\
\-\ melanoma\ \(92\)\
\-\ lung\ \(1237\)\
\-\ lesion\ \(3405\)\
\-\ gastrointestinal\ \(52\)\
\-\ determined\ \(96\)\
\-\ consistent\ \(1042\)\
\-\ breast\ \(862\)\
\-\ 72\ \(132\)\
\-\ 15\ \(862\)\
